Back to Search
JEFFREY NEWCOMER, MD
MD
Pulmonary Disease Physician
NPI: 1538256086Individual
Specialties, Licenses & Credentials
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
6217(NH)042-0008703(VT)
Research & Publications (20)
Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents.
PMID 19147694·Am J Psychiatry·2009
8-other
Budesonide induction and maintenance therapy for Crohn's disease during pregnancy.
PMID 18680195·Inflamm Bowel Dis·2009
3-trial
The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.
PMID 19526626·Pharmacoepidemiol Drug Saf·2009
8-other
Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.
PMID 19142103·J Clin Psychopharmacol·2009
8-other
A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.
PMID 19358783·J Clin Psychiatry·2009
4-observational
Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care.
PMID 19220173·Med J Aust·2009
6-review
Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes.
PMID 19244091·Diabetes Care·2009
8-other
Obesity among those with mental disorders: a National Institute of Mental Health meeting report.
PMID 19285199·Am J Prev Med·2009
8-other
Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses.
PMID 19570499·J Clin Psychiatry·2009
4-observational
Elevating the standard of care in the management of cardiometabolic risk factors in patients with mental illness. Conclusion: summary and recommendations.
PMID 18567983·CNS Spectr·2008
8-other
A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine.
PMID 18605811·J Clin Psychiatry·2008
4-observational
Review: children and adolescents with schizophrenia spectrum disorders respond to antipsychotics, but are susceptible to adverse events.
PMID 18669683·Evid Based Ment Health·2008
8-other
Long-term changes in weight and plasma lipids during maintenance treatment with ziprasidone.
PMID 17637612·Neuropsychopharmacology·2008
3-trial
Introduction: cardiovascular disease and metabolic risk factors in patients with mental illness.
PMID 18567978·CNS Spectr·2008
8-other
Addressing cardiometabolic risk during treatment with antipsychotic medications.
PMID 18852570·Curr Opin Psychiatry·2008
6-review
Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data.
PMID 18251625·J Clin Psychiatry·2008
8-other
Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine.
PMID 18973991·Schizophr Res·2008
4-observational
Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges.
PMID 18370570·J Clin Psychiatry·2008
8-other
Integrating general health care in private community psychiatry practice.
PMID 17685730·J Clin Psychiatry·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 590 COURT ST
KEENE, NH 03431 - Phone
- (603) 354-5454
Quick Facts
- NPI
- 1538256086
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile